Extrapulmonary Neuroendocrine Carcinoma — An Interview with Dr Jonathan Strosberg on Current and Future Management (Companion Faculty Lecture)
Research To Practice | Oncology Videos
00:00
Introduction to DLL3 as a Therapeutic Target
Strosberg defines DLL3 biology and explains why cell‑surface DLL3 is targetable in neuroendocrine cancers.
Play episode from 17:47
Transcript
